logo

Galapagos Nv.. (GLPG)



Trade GLPG now with
  Date
  Headline
10/4/2021 1:26:30 AM Galapagos Completes Enrollment For DIVERSITY Phase 3 Study With Filgotinib In Crohn's Disease
7/10/2021 9:03:35 AM Galapagos Presents New Post-hoc Analyses Of Data From SELECTION Phase 3 Program Of Filgotinib At ECCO
2/10/2021 9:04:18 AM Galapagos, Gilead Discontinue ISABELA Phase 3 Trials In Idiopathic Pulmonary Fibrosis
4/27/2018 7:32:39 AM RBC Capital Markets Is Lowering Galapagos NV.. (GLPG) 4Q18 Estimate To -1.04 From -1.02
4/27/2018 7:32:24 AM RBC Capital Markets Is Increasing Galapagos NV.. (GLPG) 3Q18 Estimate To -0.90 From -1.00
4/27/2018 7:32:14 AM RBC Capital Markets Is Increasing Galapagos NV.. (GLPG) 2Q18 Estimate To 0.83 From -0.94
4/27/2018 7:31:52 AM RBC Capital Markets Is Cutting Galapagos NV.. (GLPG) 2020 Estimate To -5.34 From -5.30
4/27/2018 7:31:22 AM RBC Capital Markets Is Increasing Galapagos NV.. (GLPG) 2019 Estimate To -5.55 From -5.71
4/27/2018 7:31:08 AM RBC Capital Markets Is Increasing Galapagos NV.. (GLPG) 2018 Estimate To -3.51 From -3.88